<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00701051</url>
  </required_header>
  <id_info>
    <org_study_id>CDA-2-039-08S</org_study_id>
    <secondary_id>H-27940</secondary_id>
    <secondary_id>5P30AG028747-05</secondary_id>
    <nct_id>NCT00701051</nct_id>
  </id_info>
  <brief_title>Exercise Training and Glucose Metabolism in Aging</brief_title>
  <official_title>Aging, Angiogenesis and Metabolic Responses to Aerobic Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes and its associated complications affect more than 20 million Americans, and the
      prevalence of type 2 diabetes and impaired glucose tolerance rises dramatically with age such
      that 40% of Americans over age 60 are affected. In older adults, glucose metabolism may be
      affected by reduced skeletal muscle capillary supply, which limits insulin, glucose, and
      oxygen delivery to skeletal muscle. Reduced capillary supply to skeletal muscle is found in
      older individuals with impaired glucose tolerance and we hypothesize that this is due to
      reduced vascular growth factor expression, and chronic inflammation. Further, we hypothesize
      that reversal of a sedentary lifestyle through aerobic exercise training will increase
      insulin signaling and vascular growth factor expression, as well as decrease inflammation, to
      increase capillary supply to skeletal muscle, which contributes to improved glucose
      metabolism in older adults. This study will: 1) Determine the mechanisms underlying reduced
      skeletal muscle capillarization in older adults with impaired glucose tolerance; and 2)
      Determine the effect of aerobic exercise training-induced increases in skeletal muscle
      capillarization on glucose metabolism in older adults.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Baseline Glucose Utilization</measure>
    <time_frame>baseline</time_frame>
    <description>Insulin-stimulated glucose uptake</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose Utilization (Pre/Post Intervention)</measure>
    <time_frame>baseline, 24 weeks, 26 weeks</time_frame>
    <description>Insulin-stimulated glucose uptake</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Baseline Skeletal Muscle Capillarization</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Skeletal Muscle Capillarization (Pre/Post Intervention)</measure>
    <time_frame>baseline, 24 weeks, 26 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline 2-hour Postprandial Glucose</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-hr Post-prandial Plasma Glucose Level</measure>
    <time_frame>baseline, 24 weeks, 26 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Cardiorespiratory Fitness</measure>
    <time_frame>baseline</time_frame>
    <description>maximal oxygen consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory Fitness</measure>
    <time_frame>baseline, 24 weeks, 26 weeks</time_frame>
    <description>Maximal oxygen consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Composition (%Fat)</measure>
    <time_frame>baseline, 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Impaired Glucose Tolerance (Prediabetes)</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Older adults, normal glucose tolerance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Older adults, impaired glucose tolerance</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Aerobic exercise training</intervention_name>
    <description>24 weeks of aerobic exercise training: 3 times per week, 60 minutes per session, at 70% of maximal aerobic capacity</description>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Detraining (cessation of exercise)</intervention_name>
    <description>Cessation of exercise for 2 weeks</description>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 50-75 years

          -  Non-smoker &gt;2 years

          -  Body mass index = 18-35 kg/m2

        Exclusion Criteria:

          -  History of CAD or cerebrovascular disease that would preclude exercise

          -  Implantable defibrillator

          -  Active cancer

          -  Chronic pulmonary, thyroid, renal, liver, or hematological disease

          -  HIV positive or prone to malnutrition

          -  Sickle cell anemia

          -  Type 1 diabetes, or currently on medication to treat type 2 diabetes

          -  Poorly-controlled type 2 diabetes

          -  Poorly-controlled hypertension

          -  Taking medications including: beta-blockers, oral steroids, warfarin, certain statins,
             hormone replacement therapy (HRT), oral contraceptives (OCP), thiazolidinediones
             (TZD), or chronic steroids or nonsteroidal analgesics (NSAIDS) that may not be safely
             discontinued temporarily for specific procedures (i.e. for 72 hours prior)

          -  Allergic to lidocaine or heparin

          -  Recent weight change (&gt;5kg in 3 months)

          -  Currently pregnant or nursing

          -  Physical impairment limiting exercise

          -  Dementia or unstable clinical depression
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven J. Prior, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Maryland Health Care System, Baltimore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Maryland Health Care System, Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2008</study_first_submitted>
  <study_first_submitted_qc>June 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <results_first_submitted>January 26, 2015</results_first_submitted>
  <results_first_submitted_qc>March 23, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 6, 2015</results_first_posted>
  <last_update_submitted>March 23, 2015</last_update_submitted>
  <last_update_submitted_qc>March 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Older Adults</title>
        </group>
        <group group_id="P2">
          <title>Older Adults - Normal Glucose Tolerance</title>
          <description>Normal Glucose Tolerance. Participants assigned to group after Period 1: Screening</description>
        </group>
        <group group_id="P3">
          <title>Older Adults - Impaired Glucose Tolerance</title>
          <description>Impaired Glucose Tolerance. Participants assigned to group after Period 1: Screening</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Screening</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="90">Arm assignment not known until baseline testing; both arms included in this number</participants>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31">Arm assignment not known until baseline testing; both arms included in this number</participants>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Failed Screening</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Time conflicts</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Exercise Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">Participants assigned to Normal or Impaired glucose tolerance arm after screening.</participants>
                <participants group_id="P2" count="19">Participants assigned to group after Period 1: Screening</participants>
                <participants group_id="P3" count="12">Participants assigned to group after Period 1: Screening</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>time conflict; non-study related illness</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Detraining Intervention (Optional)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="6">Participation in this period was optional.</participants>
                <participants group_id="P3" count="6">Participation in this period was optional.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Older Adults - Normal Glucose Tolerance</title>
          <description>Normal Glucose Tolerance</description>
        </group>
        <group group_id="B2">
          <title>Older Adults - Impaired Glucose Tolerance</title>
          <description>Impaired Glucose Tolerance</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="31"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" spread="7"/>
                    <measurement group_id="B2" value="60" spread="8"/>
                    <measurement group_id="B3" value="60" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Baseline Glucose Utilization</title>
        <description>Insulin-stimulated glucose uptake</description>
        <time_frame>baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Older Adults - Normal Glucose Tolerance</title>
            <description>Normal Glucose Tolerance</description>
          </group>
          <group group_id="O2">
            <title>Older Adults - Impaired Glucose Tolerance</title>
            <description>Impaired Glucose Tolerance</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Glucose Utilization</title>
          <description>Insulin-stimulated glucose uptake</description>
          <units>µmol/kgFFM/pmol insulin/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0062" spread=".00008"/>
                    <measurement group_id="O2" value="0.0035" spread="0.0004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline 2-hour Postprandial Glucose</title>
        <time_frame>baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Older Adults - Normal Glucose Tolerance</title>
            <description>Normal Glucose Tolerance</description>
          </group>
          <group group_id="O2">
            <title>Older Adults - Impaired Glucose Tolerance</title>
            <description>Impaired Glucose Tolerance</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline 2-hour Postprandial Glucose</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107" spread="2"/>
                    <measurement group_id="O2" value="160" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Glucose Utilization (Pre/Post Intervention)</title>
        <description>Insulin-stimulated glucose uptake</description>
        <time_frame>baseline, 24 weeks, 26 weeks</time_frame>
        <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Older Adults</title>
            <description>Normal and Impaired Glucose Tolerance</description>
          </group>
        </group_list>
        <measure>
          <title>Glucose Utilization (Pre/Post Intervention)</title>
          <description>Insulin-stimulated glucose uptake</description>
          <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
          <units>µmol/kgFFM/pmol insulin/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.041" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24-week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.052" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>26-week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.048" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2-hr Post-prandial Plasma Glucose Level</title>
        <time_frame>baseline, 24 weeks, 26 weeks</time_frame>
        <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Older Adults</title>
            <description>Normal and Impaired Glucose Tolerance</description>
          </group>
        </group_list>
        <measure>
          <title>2-hr Post-prandial Plasma Glucose Level</title>
          <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24-week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="153" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>26-week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142" spread="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Cardiorespiratory Fitness</title>
        <description>maximal oxygen consumption</description>
        <time_frame>baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Older Adults - Normal Glucose Tolerance</title>
            <description>Normal Glucose Tolerance</description>
          </group>
          <group group_id="O2">
            <title>Older Adults - Impaired Glucose Tolerance</title>
            <description>Impaired Glucose Tolerance</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Cardiorespiratory Fitness</title>
          <description>maximal oxygen consumption</description>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.3"/>
                    <measurement group_id="O2" value="1.7" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Baseline Skeletal Muscle Capillarization</title>
        <time_frame>baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Older Adults - Normal Glucose Tolerance</title>
            <description>Normal Glucose Tolerance</description>
          </group>
          <group group_id="O2">
            <title>Older Adults - Impaired Glucose Tolerance</title>
            <description>Impaired Glucose Tolerance</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Skeletal Muscle Capillarization</title>
          <units>capillaries/mm2</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="313" spread="13"/>
                    <measurement group_id="O2" value="246" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Skeletal Muscle Capillarization (Pre/Post Intervention)</title>
        <time_frame>baseline, 24 weeks, 26 weeks</time_frame>
        <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Older Adults</title>
            <description>Normal and Impaired Glucose Tolerance</description>
          </group>
        </group_list>
        <measure>
          <title>Skeletal Muscle Capillarization (Pre/Post Intervention)</title>
          <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
          <units>capillaries/mm2</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="289" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24-week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="341" spread="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>26-week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="361" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiorespiratory Fitness</title>
        <description>Maximal oxygen consumption</description>
        <time_frame>baseline, 24 weeks, 26 weeks</time_frame>
        <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Older Adults</title>
            <description>Normal and Impaired Glucose Tolerance</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiorespiratory Fitness</title>
          <description>Maximal oxygen consumption</description>
          <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
          <units>L/Min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24-week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>26-week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Composition (%Fat)</title>
        <time_frame>baseline, 24 weeks</time_frame>
        <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Older Adults</title>
            <description>Normal and Impaired Glucose Tolerance</description>
          </group>
        </group_list>
        <measure>
          <title>Body Composition (%Fat)</title>
          <population>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm) due to the sample size of this pilot study; thus, data are reported for the entire group of participants.</population>
          <units>percentage of fat</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24-week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Older Adults</title>
          <description>Glucose tolerance data were analyzed as a continuous variable (combining Arms) as opposed to categorical (i.e., within each Arm); thus, data are reported for the entire group of participants.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="90"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="90"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <description>Fall due to distraction while walking</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="90"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Steven J. Prior, PhD</name_or_title>
      <organization>Baltimore VA Medical Center</organization>
      <phone>410-605-7000 ext 4129</phone>
      <email>steven.prior@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

